Background: Smoking among cancer survivors increases the risk of late effects and second cancers. This article reports on Partnership for Health-2 (PFH-2)—an effort to develop an effective and scalable version of Partnership for Health (PFH), which was a previously tested peer-delivered telephone counseling program that doubled smoking cessation rates among childhood cancer survivors who smoke.
Objective: This paper presents results from a randomized controlled trial evaluating the effectiveness of PFH-2 in targeted and tailored Web-based versus print formats. The overall goal was to determine whether the intervention outcomes in these self-guided scalable formats approximate what was found in a more intensive telephone counseling program.
Methods: This study was a randomized controlled trial with a 15-month follow-up that included 374 smokers who were survivors of childhood or young adult cancers, recruited from five survivorship clinics. Participants were randomly assigned to a Web-based or print format of the PFH intervention; all had access to free pharmacotherapy. The website was designed to provide new content at each log-on, and a peer counselor moderated a forum/chat feature. The primary outcome was smoking status at 15 months post randomization.
Results: In total, 58.3% (77/132) of Web participants logged on at least once (mean visits 3.25). Using multiple imputation methods for missing data, there were similar rates of cessation in the two arms (print: 20/128, 15.6%; Web: 33/201, 6.4%), and no differences in quit attempts or readiness to quit. The quit rates were equivalent to those found in our previous telephone counseling intervention. There were high rates of satisfaction with both of the PFH-2 interventions.
Conclusions: The print and Web formats yielded equivalent levels of success to those found with our telephone-delivered intervention and are comparable to other Internet treatment studies. This study provides important options for survivorship programs that may not have resources for interpersonal forms of cessation counseling. Efforts to increase patient use of the interventions may result in higher cessation rates.
Trial Registration: Clinicaltrials.gov NCT00588107; http://clinicaltrials.gov/ct2/show/NCT00588107 (Archived by WebCite at http://www.webcitation.org/6K1gJtFEC).
Remarkable improvements in the treatment and long-term survival of childhood and young adult cancer survivors have resulted in prevention of adverse late effects and second primary cancers being a key part of survivorship care [- ]. Smoking rates among this population are substantial [ - ]. In the Childhood Cancer Survivor Study, the largest US cohort of childhood cancer survivors, 28% of survivors reported having smoked at least 100 cigarettes in their lifetime and 17% reported current cigarette smoking [ ]. In the British Childhood Cancer Survivor Study, a population-based cohort of 17,981 survivors, 20.0% were current regular smokers and 29.8% were regular smokers but no longer are [ ].
This team’s previous work has demonstrated the efficacy of Partnership for Health (PFH), a survivor-focused peer-delivered telephone counseling intervention for smoking cessation. PFH led to a doubling in quit rates compared with usual care and the intervention effect was sustained over 2-5 years of follow-up [, ]. The connection that the peer-delivered intervention provided between survivors was an important way to engage participants in the intervention. However, it is challenging to scale interventions that include ongoing counseling.
A recent evaluation of existing infrastructure for delivering smoking cessation services in the context of survivorship programs revealed relatively few resources; only 3% of programs assessed smoking status at every visit, as recommended by Public Health Service (PHS) guidelines, and only 25% offered cessation services . Further, cancer survivors are quite geographically dispersed and thus, effective interventions are needed that can be scaled easily and delivered remotely regardless of survivors’ location. The present study focused on the adaptation of the PFH peer-delivered intervention for a Web- and print-based format as a way to increase the intervention’s dissemination potential and sustainability. We selected Web- and print-based interventions because of the relatively high penetration of Internet access in the target age group [ ] and because these formats could be integrated easily into standard practice at survivorship programs across the country, compared with telephone-based interventions.
This paper presents results from a randomized control trial evaluating the effectiveness of Partnership for Health-2 (PFH-2) in targeted and tailored Web-based versus print formats. The overall goal was to determine the outcomes for these self-guided scalable formats and whether they approximate what was found in a more intensive telephone counseling program. Our hypothesis was that the Web format would yield higher quit rates than print and would be similar in effectiveness to that found in the original PFH counseling intervention.
PFH-2 was conducted in collaboration with five cancer centers in the United States and Canada, with Institutional Review Board (IRB) approval at all sites. The study was also advertised on childhood and young adult survivorship websites. Eligibility included: diagnosed with cancer before age 35, currently between ages 18-55, completed cancer treatment for ≥2 years, mentally able to provide informed consent, reachable by telephone, able to speak English, and a current smoker (defined as smoking within the previous 30 days). Participants were informed that the study was examining different ways to deliver health information, including information about tobacco use, to survivors. They were not required to be interested in smoking cessation in order to participate. Baseline data collection began on December 2005 and follow-up data collection ended in October 2009.
A preliminary screen for eligiblity was performed at each site via medical record review or brief telephone screening. After consent for sharing contact information was obtained, contact information was forwarded to the survey team to verify eligibility, obtain informed consent for study participation, and administer the baseline telephone survey.
PFH-2 Study Design
PFH-2 was a stratified randomized controlled trial with cancer center as strata. The goal was to test two scalable intervention formats for smoking cessation among childhood and young adult survivors, developed from an evidence-based intervention, and to determine whether the Web intervention, with the advantages that an interactive website has to offer, would outperform tailored and targeted print materials. Participants were randomized to one of two intervention conditions within strata, in a 5:3 randomization scheme: (1) PFH-2 Print Materials Intervention, or (2) PFH-2 Web Intervention. The random allocation sequence was generated by the study biostatistician. Randomization was done by the survey team and supervised by the biostatistician, following completion of the baseline survey. Study design is provided in detail elsewhere . Intervention goals for both conditions included: (1) assess and enhance motivation to change, (2) address ambivalence about behavior change, (3) provide social support, (4) assess and build self-efficacy, (5) increase awareness of risks, (6) identify and address barriers to change, and (7) address nicotine dependence. Both conditions included: (1) a letter encouraging smoking cessation from the site oncologist, developed based on the principles of the National Cancer Institute’s “5 A’s” smoking counseling guidelines, (2) free pharmacotherapy for participants and spouses/significant others who want to quit, and (3) tailored and targeted self-help content (Web or print) addressing participant-specific barriers to change and other survivor-related topics of interest. The intervention period was 6 months and a follow-up survey was completed by telephone at 15 months after randomization.
PFH-2 Print Materials Intervention
The Print Materials arm received tailored and targeted self-help materials that were developed for the peer counselor condition in PFH-1. The materials were organized into a series of manuals, based on readiness to change , that addressed participant-specific barriers to change and other survivor-related topics of interest (eg, addressing depression, handling stress, managing weight). The manuals were designed to be as interactive as possible, with worksheets and opportunities for personalizing the content included throughout. Testimonials and stories of other survivors’ experiences were used to provide the survivor-to-survivor connection. Both PFH-2 conditions included other key features of the original PFH peer-delivered intervention, including a letter encouraging smoking cessation from the site oncologist and free pharmacotherapy (nicotine patch or Zyban) for themselves and any smoking partner/spouse who wished to quit. Those who were interested in pharmacotherapy contacted study staff and provided permission to contact their health care provider for approval using a fax-back form. We also sent the provider a copy of the pamphlet “Helping Smokers Quit: A guide for primary care clinicians” (US Department of Health and Human Service/Agency for Health Care Policy and Research) and a basic fact sheet about adult survivors of cancer. The pharmacotherapy was also sent to the provider and distributed to the patient by his or her office.
A baseline feedback report (BFR) was generated for each individual and sent between 5 and 10 business days following completion of the baseline survey. The BFR reflected information that patients gave on the baseline survey about their readiness to quit, perceived risk, nicotine dependence, and, based on these factors, which intervention manual to start with, drawing on approaches we have used previously [, ]. The BFR also gave basic facts about cancer treatment and illustrated how cancer, cancer treatment, and smoking affects many of the same organs (see ). The Print Materials condition was designed to reflect as many of the realities as possible of how the intervention might be utilized when scaled to existing cancer survivorship clinics.
PFH-2 Web Intervention
Within 5-10 business days following completion of the baseline survey, those assigned to the Web intervention were sent log-on information. The Web intervention consisted of seven discrete tailored sessions designed to parallel the counseling sessions of the original PFH study and mirror the basic content of the PFH-2 print materials. The content was dynamically tailored, matching the participants’ stage of readiness. Upon first log-on, participants saw their BFR, described above, on their home page. The home page also highlighted active components of the intervention that participants had not yet navigated. Patients saw refreshed content on the home page as they progressed from session to session. A peer counselor moderated the website’s discussion forum and served as a resource for questions.
Participants who never logged in or stopped using the site received additional email prompts that highlighted content that survivors might find particularly important or engaging, along with biweekly emailed newsletters. Those who had not accessed the website within 11 weeks were sent a final letter along with the print materials to increase the likelihood of some exposure to the intervention content and to approximate likely approaches in a clinic setting. Participants had access to the website for 6 months regardless of their log-in status. For quality assurance purposes, several “test participants” were created and followed throughout the implementation period to identify glitches or issues with the Web system. These “participants” were not included in the tracking data and did not impact on intervention delivery in any way.
Sociodemographics and Medical History
Age, gender, race, ethnicity, marital status, education, height, weight, employment status, type of cancer, and cancer treatment were assessed.
Internet Access and Utilization
Internet access and utilization were measured with questions about whether participants owned a computer, whether they had access to the Internet at home and/or work, and how frequently they used a computer, email, and the Internet .
“Smoking status” was assessed by self-reported assessment of smoking, even a puff, in the past 30 days. The bogus pipeline procedure was used to increase the accuracy of self-report, following standard implementation methods [, ]. Specifically, participants were informed that they may be asked to provide a saliva sample to confirm their smoking status. This procedure has been found to improve the quality of self-reported smoking behavior. “Nicotine dependence” was assessed based on number of minutes after waking that participants smoked their first cigarette [ ] (<30 minutes, nicotine dependent; ≥30 minutes, not nicotine dependent). “Quit attempts” were assessed by the number of quits in the previous 12 months with at least 24 hours abstinence. “Use of pharmacotherapy” was assessed with two questions about whether participants had ever used Zyban or nicotine replacement therapy to quit smoking.
“The Stages of Change Scale” assessed motivation to quit smoking , according to four categories: (1) precontemplation: not seriously thinking about quitting in the next 6 months; (2) contemplation: seriously thinking about quitting in the next 6 months; (3) preparation: intending to quit in the next month and have tried to quit in the past year; and (4) action: not currently smoking and quit within the past 6 months. “Self-efficacy” was assessed related to participants’ level of confidence that they could quit smoking in the next 1 and 6 months [ ].
Household and Workplace Smoking Policy
Participants were asked about rules regarding smoking at home and work (smoking unrestricted inside the building/house, limited to certain rooms, or forbidden inside the building/house).
“Cancer-related distress” was assessed with the Intrusive Thoughts subscale of the Impact of Events Scale (IES), which measures frequency with which thoughts regarding cancer recurrence intrude into consciousness . “Perceived control” was assessed with a 3-item scale that measured the degree to which participants felt they could control physical side effects, future health, and chance of a cancer recurrence [ ]. “Perceived vulnerability” was assessed with a question about the likelihood of experiencing serious health problems in the future [ , ]. “Depression” was measured with the 2-item Prime MD scale [ ].
Contact With the Health Care System
Participants were asked if they had a regular health care provider and if they had been seen by their primary care physician or their oncologist in the past year.
Use of the Web-based intervention was assessed using Web analytics. Use of the print intervention was assessed on the follow-up survey, with questions about the percentage of materials read and frequency of use.
Original sample size calculations were adjusted due to the discovery during implementation that the participating survivorship programs’ estimates of smokers were an over-estimate. Thus, we used a 5:3 allocation scheme to ensure an adequate sample size to evaluate the use of the Web-based intervention. With this approach, we had 71% power to detect a difference of 9% in quit rate between the Web and print groups. Baseline comparisons of patient characteristics between intervention arms were assessed. Depression level was the only variable of significance in this comparison and was, in addition to site, controlled for in all future analyses. All outcome analyses were conducted using multiple imputation methods based on the assumption of arbitrary missing patterns and thus used Markov chain Monte Carlo methods. This assumes multivariate normality to impute missing values (11.7%, 27/230 of the Web group and 12.5%, 18/144 of the print group were missing at follow-up). All analyses followed procedures described in the SAS OnlineDoc Version 8 for multiple imputation . Logistic regression models were created to assess the impact of a priori determined predictor variables on the primary outcome—smoking status at follow-up. Variables that were significant in these models were considered potential variables to be entered into a multivariable logistic model predicting smoking status at follow-up. Any a priori determined variable (such as study site and depression level) were included in the final model selection regardless of bivariate significance. A parsimonious model that made clinical sense was developed by a process of forward and backward stepwise regression based on the individual variable significance in the model and the effect its removal had on other variable coefficients in the model. This was followed by assessing potential interaction effects, effect modifiers, and confounders. For the secondary outcome variables—quit attempts and readiness to quit smoking—similar model development occurred using polytomous logistic regression models with categorical outcome. All analyses were conducted in SAS Version 9.3.
We assessed eligibility among 4399 survivors; 4025 people were excluded (35.88%, 1444/4025 were not reached; the majority of the remainder were ineligible due to smoking status); 46.7% (374/801) of eligible survivors were enrolled in the study. In total, 88.0% (329/374) of enrollees completed the 15-month follow-up (see). In , “lost to follow-up” were subjects for which no contact information was available at the 15-month time period whereas “missing” were those subjects who did not respond to the survey after multiple contact attempts.
Mean age at enrollment was 32 years (SD 7.94) and at cancer diagnosis was 12 years (SD 8.06). The sample was evenly split by gender (51.3%, 192/374 male) and was predominantly white (86.4%, 323/374). In total, 36.1% (135/374) had a high school education or less and 29.7% (111/374) had at least a college degree. About half (176/374) were married or living with a partner and the majority (79.4%, 297/374) were employed in the last year. There were no differences between the two arms at baseline on any demographic or cancer-related variables (see).
A total of 59.9% (224/374) of the sample smoked less than one pack of cigarettes per day (range <1 to 60; mean 10/day). About half of the sample was nicotine dependent. The majority (63.1%, 236/374) were in preparation to quit smoking and 55.9% (209/374) screened positive for possible depression.
There were no differences in any baseline demographic variables among completers and drop-outs except employment status; drop-outs were more likely to be employed.
Primary Outcomes—Smoking Cessation
There were no significant differences between the two interventions arms in terms of smoking status at follow-up. At the final assessment, 16.5% of Web participants (22/132) and 15.5% of print participants (20/127) reported being abstinent for the previous 30 days (see).
Several factors were associated with smoking abstinence in multivariate analyses, including gender (P≤.04, males less likely to have quit at follow-up) and cancer treatment factors (higher cessation rates were associated with a cancer diagnosis of leukemia [P=.03] or non-Hodgkin’s lymphoma [P=.01], not having received radiation [P=.01], and having received surgery [P=.01]). Higher levels of perceived vulnerability for serious illness in the future was marginally associated with lower rates of cessation (P=.08 for more likely vulnerable) and less restrictive rules about smoking in the home were associated with significantly lower rates of cessation (P=.05).
An exploratory comparison of quit rates in the original PFH peer-delivered telephone intervention with the current Web and print condition suggests that the PFH-2 interventions attained equivalent levels of cessation. The original telephone-delivered intervention resulted in quit rates of 15% at 12-month follow-up. Although this was not a randomized comparison, these results do suggest that both Web- and print-based intervention methods developed specifically for cancer survivors do have a similar level of intervention impact to that found with a more intensive peer-counseling telephone intervention.
Secondary Outcomes—Quit Attempts and Readiness to Change
There were no significant differences between the two arms in terms of quit attempts (see). On average, 35.1% (91/259) of participants made no quit attempts, 37.8% (98/259) made limited (1-3) attempts, and 27.0% (70/259) made extensive (4+) quit attempts over the 15-month follow-up period.
Demographic factors associated with quit attempts in multivariable analyses included male gender (P.001 and P=.06 for limited and extensive quit attempts, respectively), having less education (P=.01 for limited quit attempts), using pharmacotherapy (P<.001), being a more frequent computer user (P=.03-.06), perceiving a moderate (P=.03) or high level of vulnerability (P=.07) to serious future illness (for limited quit attempts), and not being nicotine dependent (P=.002 for extensive attempts).
There were also no significant differences between the two arms in terms of impact on readiness to quit smoking. Only two variables, using pharmacotherapy and nicotine dependence, were associated with readiness to quit in multivariable analyses: using pharmacotherapy was associated with being in the action (OR 5.33, 95% CI 1.20-23.64) (P=.03) and preparation stage (OR 6.05, 95% CI 1.81-20.17) (P=.01) (vs precontemplator). Those who were not nicotine dependent were more likely to be in later stages at the follow-up (OR 4.27, 95% CI 1.21-12.95) (P≤.01) and preparation versus precontemplation (OR 2.03, 95% CI 1.02-4.02) (P=.006).
|Treatment condition||P valuea|
|≤ high school or GED||43||34.1||75||36.9|
|Some college or training after college||50||39.7||63||31.0|
|Age (LS means)||33.59||32.50||.23|
|Employed, past year||97||77.0||159||78.3||.46|
|Married/living with partner||61||48.4||100||49.3|
|Never married and not living with partner||55||43.7||83||40.9|
|Divorced/no longer living with partner||12||9.5||18||8.9|
|Spent at least part of the day worried about getting cancer again in past week||.13|
|Impact of Events scale, Intrusive Thoughts subscale - categorized||.22|
|Screened positive for possible depression||85||67.5||100||49.3||.003|
|Perceived personal control (LS means)||10.88||11.76||.07|
|Perceived risk for serious health problems in the future||.61|
|No chance/very unlikely/unlikely||29||23.0||41||20.2|
|Very likely/certain to happen||25||19.8||44||21.7|
|Stage of change||.86|
|Computer use at baseline||.79|
|Less than daily, but monthly or more||20||15.9||43||21.2|
|Less than monthly or never||27||21.4||34||16.7|
aControlling for site.
|Abstainer vs smoker at follow-up|
(adjusted for site)
|P value||Adjusted OR (95% CI)|
|Screened positive for possible depression|
|Hodgkins Disease||1.00||1.00 (0.31-3.20)|
|CNS malignancy||.63||0.65 (0.12-3.68)|
|Non-Hodgkins Lymphoma||.01||6.35 (1.48-27.17)|
|Bone cancer||.86||1.13 (0.27-4.68)|
|Received radiation for CA|
|Received surgery for CA|
|Perceived vulnerability for serious illness in future|
|No chance/very unlikely/unlikely||REF||1.00|
|Moderate chance||.77||0.88 (0.37-2.11)|
|Very likely/certain to happen||.12||0.45 (0.16-1.23)|
|Rules about smoking in home at follow-up|
|There are no rules||.05||0.38 (0.14-0.98)|
|People can only smoke in certain rooms||.16||0.35 (0.08-1.53)|
|People cannot smoke inside||REF||1.00|
aREF: reference point.
|4 or more times vs none|
(adjusted for site)
|1-3 times vs none|
(adjusted for site)
|P value||Adjusted OR (95% CI)||P value||Adjusted OR (95% CI)|
|Web||.90||1.05 (0.51-2.18)||.96||1.02 (0.54-1.90)|
|Male||.06||2.06 (0.98-4.33)||.01||2.27 (1.18-4.40)|
|White||.09||0.38 (0.12-1.18)||.01||0.28 (0.10-0.74)|
|Screened positive for possible depression|
|Yes||.30||0.67 (0.32-1.43)||.60||0.83 (0.43-1.63)|
|Did not complete HS / GED||.78||1.34 (0.16-11.36)||.01||5.24 (1.50-18.33)|
|Completed HS / GGED||.23||0.53 (0.19-1.49)||.58||0.77 (0.31-1.93)|
|Some college or training after HS||.79||1.13 (0.45-2.85)||.64||1.23 (0.51-2.97)|
|Use medication to help quit smoking at follow-up|
|Yes||<.001||9.45 (2.90-30.74)||<.001||9.27 (3.04-28.28)|
|Daily||.03||3.33 (1.12-9.90)||.06||2.20 (0.97-4.96)|
|< than daily, but monthly or more||.03||4.01 (1.12-14.40)||.04||2.89 (1.05-7.95)|
|< than monthly/never||REF||1.00||REF||1.00|
|Experience any serious illness in future|
|No chance/very unlikely/unlikely||REF||1.00||REF||1.00|
|Moderate chance||.24||1.93 (0.64-5.80)||.03||3.33 (1.16-9.56)|
|Likely||.36||1.67 (0.55-5.10)||.07||2.52 (0.91-6.97)|
|Very likely/certain to happen||.52||0.69 (0.22-2.17)||.55||1.39 (0.47-4.09)|
|Smoke within 30 minutes of waking|
|No||.002||3.70 (1.66-8.25)||.15||1.65 (0.83-3.26)|
aREF: reference point.
Of the Web participants, 58.3% (77/132) logged on at least once (mean visits 3.25). Among visitors to the site, 13% (10/77) logged on once, 20% (15/77) twice, 13% (10/77) three times, and 54% (42/77) logged on four or more times (range 6-98 times). Those who reported using the website more frequently (3+ times) had higher quit attempts and lower smoking rates at follow-up, compared with less frequent users (see). We explored abstinence as an outcome related to different levels of use between groups; however, due to the distribution of quitters across intervention groups and use patterns, attempts to model the relationships were unstable.
Among the print condition participants, 58.3% (74/127) reported reading most or all of the print materials. About half reported using the materials on multiple occasions. Those who used more of the print materials (most/all) had higher quit attempts and lower smoking rates at follow-up, compared with those who used the materials less.
In total, 13.9% (36/259) of participants requested pharmacotherapy, with no differences between arms. Among those who requested this assistance, it was provided in 87% (31/36) of the cases; the primary reason for not providing it was that the participant did not have a regular physician who could confirm that there were no contraindications.
Satisfaction With Intervention
Of the Web participants who logged in, 87.9% (116/132) reported being satisfied or very satisfied with the site. Further, 75.8% (100/132) reported that the site provided new information about smoking, 83.3% (110/132) felt it provided new information about survivorship, and the majority felt that it was updated often enough; 81.1% (107/132) would recommend the site to other survivors.
In the print condition, 92.1% (117/127) reported being satisfied or very satisfied with the materials. Further, 93.7% (119/127) reported that the materials provided new information about smoking and 89.0% (113/127) felt they provided new information about survivorship; 88.2% (112/127) would recommend the materials to other survivors.
Access to the Web Intervention
In total, 79.9% (299/374) of the sample owned a computer and had access to the Internet at home and/or work; the majority (77.0%, 288/374) used the Internet at least once per week. Those who did not have regular Internet access had less education (P=.001), were more likely to be unemployed (P=.001), divorced (P=.001), and to be heavier smokers (P=.003). We offered MSN TV to those who did not have regular Internet; roughly two-thirds declined it.
|Quit Attempts||Smoking Rate (cigs/day)|
This paper assesses the efficacy of a print versus Web version of the Partnership for Health intervention. Both interventions were developed to address scalability of smoking cessation interventions among childhood and young adult cancer survivors. PFH-2 was designed to translate core components of PFH  to more scalable formats, and to determine whether equivalent levels of cessation could be achieved via a website tailored to cancer survivorship. Although we did indeed find that the PFH-2 intervention achieved similar levels of cessation to the peer counseling intervention, contrary to our hypothesis, there were no differences in cessation rates in the print versus Web arms and no differences in quit rates or changes in readiness to quit. Both interventions were viewed as substantive and appealing and were relatively comparable in terms of intervention “dose” based on participant report of use. These findings suggest that either the print or Web-format intervention could be recommended for survivors who smoke, as these cessation interventions yield equivalent levels of success to those found in our previous telephone-delivered intervention. The outcomes are also comparable to other Internet treatment studies [ ] and PHS clinical guidelines for cost-effective interventions.
A Web-based approach was selected because of the presumed computer affinity of this younger population, as well as the potential for dissemination. We did offer access to the Internet via MSN TV to the 20% that did not have Internet access. Surprisingly, the majority of these participants declined the offer. This may reflect an active choice among these individuals not to engage with this technology and suggests that, at least in the population of childhood and young adult cancer survivors, efforts to increase access may not be helpful. Among those who received the print materials, engagement was good, which may be preferable in some settings and to some participants.
A key issue facing any disseminated, patient-guided intervention is level of patient engagement. Low levels of intervention use is a common problem in both Web and print interventions [- ] and rapid and consistent declines in intensity of use occur over time [ , ]. A dose-response between website use and abstinence outcomes has been documented [ - ]. Consistent with this literature, in PFH-2 use of the website was associated with cessation-related efforts. Chiu and Eysenbach [ ] call for development of a research agenda targeting how to improve use of Web-based interventions, which is critical if they are to be helpful in taking more labor-intensive interventions to scale. The increasing penetration of social media and technology may present opportunities for increasing engagement, as noted by Graham et al [ , ]. Active participation in online communities is associated with higher rates of cessation, and integrating smokers into an online social network can increase support and may also increase utilization of cessation tools and nicotine replacement therapy [ ]. Text messages and Twitter could be utilized as efficient ways for peer counselors to engage survivors. The increased access to video cameras on laptops and smartphones also provides opportunities to evaluate Skype and videoconferencing as engagement strategies, although these strategies may also present issues when taken to scale. In the present study, we targeted all smokers—not just those who were interested in quitting smoking. The intervention was designed and presented with a focus on general survivorship issues, in addition to smoking, and was organized by stage of readiness to change. That said, those with less interest in cessation would be expected to have lower levels of engagement with cessation content, although integrating smoking-related information into other forms of interventions or materials for survivors may be a way to increase their reconsideration of smoking.
Use of pharmacotherapy was quite low, particularly given the high level of readiness to quit and the fact that it was available at no cost. This is somewhat puzzling, but may be a function of survivors’ heavy use of medications as part of cancer treatment and possibly survivorship, which may make them more reticent to use pharmacologic treatments for non-cancer-related issues. In 2014, CMS (Center for Medicare and Medicaid Services) programs will cover all FDA-approved medications and cessation counseling . There are very tangible and important health benefits associated with population-level access to evidence-based cessation treatments in the general population [ - ], and the benefits for survivors may be even greater, given the synergistic effects between smoking and their increased risk of late effects. Our findings suggest that while access is important, alone it may not be sufficient in this high-risk population to achieve large-scale increases in pharmacotherapy use. This is an area that warrants further research attention.
This study highlights the need to develop an effective infrastructure for delivery of smoking cessation services to childhood and young adult cancer survivors. The infrastructure for identifying smokers within long-term survivorship care programs is largely missing  and a more systematic approach to patient tracking and follow-up is needed. Survivorship programs should be strongly encouraged to follow the PHS guidelines for delivery of smoking cessation services in clinical care settings [ , ]. Given the current movement toward electronic health records [ ], it is likely that there will be greater opportunity for developing this infrastructure within survivorship programs. The American Society of Preventive Oncology recently called for a paradigm change related to cancer prevention after cancer, highlighting a critical need to reduce preventable risk factors [ ]. Tobacco use is not systematically assessed in US cancer programs—less than half of comprehensive cancer centers have a strategy in place for effective identification of tobacco use [ ] and only 28% use any tobacco-related quality improvement measures. As a result, a large proportion of smokers with cancer do not receive formal assistance with quit attempts. An important question would be whether survivorship-focused interventions are needed or if survivors could be integrated into widely available Internet-based cessation programs, such as QuitNet or BecomeAnEx. Our previous qualitative work suggests that the survivorship identity may be quite important in terms of being willing to engage in smoking cessation [ ]. However, additional experimental work to determine the added value of tailoring to survivorship would be extremely valuable.
Cancer survivors are a unique population that should be uniquely aware of risks for cancer. However, not all childhood and young adult survivors are well informed about their cancer, its treatment, and the associated late effects, in large part because of the young age at diagnosis, disease, and treatment complexity, and the fact the knowledge about late effects has been emerging over time [, ]. The Childhood Cancer Survivor Study has demonstrated that emotional distress is related to health behaviors, including smoking in long-term survivors, and subgroups that are at risk for becoming smokers (eg, lower income survivors, those with multiple medical morbidities) have higher distress levels [ , ]. A study of adolescent and young adult survivors did not find statistically significant differences between survivors and controls in terms of psychological distress or health-related quality of life, but survivors had less positive health beliefs [ ]. Of note, these survivors’ beliefs reflected their perceived bad luck and uncertainty about their health, including concerns about future medical problems (ie, health perceptions) and beliefs (ie, cognitive competence) that they have cognitive challenges that could impact their function (eg, memory, attention, intellect). These types of beliefs could impact on positive coping, such as smoking cessation.
The lack of an effective implementation infrastructure posed a challenge in the design of PFH-2, as it does in many implementation research studies. We considered comparing the PFH-1 peer counseling condition with the website. However, if we had concluded that the peer counseling was superior, we would not have moved the field forward in terms of having an evidence-based intervention that could be sustained and scaled in real-world conditions. Given that we did not have a mechanism to deploy peer counselors that would be sustainable following completion of the study, we felt it was best to learn from the peer counselor model and adapt to a sustainable format. Thus, PFH-2 was designed with the real-world constraints of survivorship care in mind and compared best survivorship-focused print materials with the website, which provided some interactivity but was more sustainable and scalable than peer counseling. This approach is consistent with several of the broad principles outlined by Kottke et al , which are necessary in order for health research to have a greater impact on patient and population health outcomes, including: (1) the needs of patients and populations determine the research agenda, (2) the research agenda addresses contextual and implementation issues, including the development of delivery and accountability systems, and (3) the research agenda determines the research methods rather than the methods determine the research agenda. Kottke and colleagues also note that the goal should be to optimize practice through research, which was the approach we took in designing PFH-2. This approach also addresses significant concerns raised within implementation science about having an increased emphasis on external validity and moving away from artificial comparisons that have little bearing on real-world care delivery [ - ]. In the interests of maximizing fidelity and ensuring a minimum intervention dose delivered, we did provide print materials to participants in the Web condition who did not access the website after 3 months. Although this means that the Web condition was not “pure”, as some participants had access to both the Web and print interventions, we felt that ethically it was important to ensure that patients received the intervention content in some form, when we knew that participants had not received it via the Web.
Study limitations should be noted. The response rate was impacted by stringent IRB requirements regarding patient contact and release of contact information to the coordinating center, which may impact on generalizability of findings. Cessation outcomes were self-reported, which is typical in population-level and Web-based studies such as this, but still a limitation ; the bogus pipeline procedure, a well-accepted strategy for increasing the accuracy of self-report, was used [ , ]. It is possible that self-report at the point of evaluation of study eligibility introduced a sampling bias. However, participants were not aware of the eligibility requirements at the time of recruitment, which minimized the likelihood of bias. Further, smokers who did not accurately report their smoking status would likely report this same inaccuracy in the context of their health care, and thus would avoid exposure to this type of intervention. Therefore, any reporting bias would not likely effect the outcome evaluation.
There are several important strengths to note. A population-based approach was used in conducting this study, identifying all potential smokers within several different survivorship programs in the United States and Canada, which contributes to the external validity of the findings. Data were conservatively analyzed using multiple imputation methods for missing data. This study builds on the previous effective PFH intervention and was designed to determine how best to deliver that intervention in a more scalable format. The study design emphasized external validity and maximizing generalizability of study findings.
Smoking cessation among childhood and young adult cancer survivors is critical. Effective evidence-based programs should be integrated into primary and survivorship care delivery on an on-going and routine basis. This study demonstrated that it was possible to achieve equivalent cessation rates with tailored and targeted Web- and print-based materials designed specifically for survivors and that these cessation rates were equivalent to those found with a more labor-intensive telephone-based intervention. These findings suggest that survivorship programs have flexibility in the format in which cessation services are delivered without sacrificing effectiveness. Patients who reported more frequent use of the materials had better cessation rates, suggesting that developing methods for increasing patient engagement in print and Web-based interventions might optimize outcomes. Future research should examine such approaches to increase engagement and should also evaluate whether survivorship-focused interventions are critical or if survivors experience equal benefits from robust Web-based interventions available to the general public.
This study was supported by grants from the National Cancer Institute, (5R01CA106914-5 and 1K05 CA124415). The authors would like to acknowledge Martha Zorn for her work on the data management and Nancy Klockson for participation in the manuscript preparation.
All authors made substantial contributions to the development of this manuscript and have given final approval of the version to be published. KE was the study PI and oversaw all aspects of the study conceptualization, design, implementation, analysis, and reporting. EP was the study biostatistician and provided input to the study design, data collection procedures, and completed all analyses. KSH provided critical input into and oversaw study implementation procedures and drafted the Methods section of this paper. JF, JO, DH, MG, LD, VT, and JdM all contributed to the study design and implementation, participated in data analysis, and contributed to the Introduction, Results, and Discussion sections of this manuscript.
Conflicts of Interest
Multimedia Appendix 1
CONSORT-EHEALTH checklist V1.6.2 .PDF File (Adobe PDF File), 997KB
- Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2010 Jul 21;102(14):1083-1095 [FREE Full text] [CrossRef] [Medline]
- Hewitt M, Weiner S, Simone J. Childhood cancer survivorship; improving care and quality of life. Washington, DC: The National Academies Press; 2003.
- Meacham LR, Sklar CA, Li S, Liu Q, Gimpel N, Yasui Y, et al. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch Intern Med 2009 Aug 10;169(15):1381-1388 [FREE Full text] [CrossRef] [Medline]
- Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009;339(Dec 08 1):b4606-b4606. [CrossRef]
- Ries L, Melbert D, Krapcho M, Mariotto A, Miller B, Feuer E, et al. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute; 2007.
- Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, Diller L, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol 2002 Mar 15;20(6):1608-1616. [Medline]
- Emmons KM, Butterfield RM, Puleo E, Park ER, Mertens A, Gritz ER, et al. Smoking among participants in the childhood cancer survivors cohort: the Partnership for Health Study. J Clin Oncol 2003 Jan 15;21(2):189-196. [Medline]
- Frobisher C, Winter DL, Lancashire ER, Reulen RC, Taylor AJ, Eiser C, British Childhood Cancer Survivor Study. Extent of smoking and age at initiation of smoking among adult survivors of childhood cancer in Britain. J Natl Cancer Inst 2008 Aug 6;100(15):1068-1081 [FREE Full text] [CrossRef] [Medline]
- Emmons KM, Puleo E, Park E, Gritz ER, Butterfield RM, Weeks JC, et al. Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study. J Clin Oncol 2005 Sep 20;23(27):6516-6523. [CrossRef] [Medline]
- Emmons KM, Puleo E, Mertens A, Gritz ER, Diller L, Li FP. Long-term smoking cessation outcomes among childhood cancer survivors in the Partnership for Health Study. J Clin Oncol 2009 Jan 1;27(1):52-60 [FREE Full text] [CrossRef] [Medline]
- de Moor JS, Puleo E, Butterfield RM, Li FP, Emmons KM. Availability of smoking prevention and cessation services for childhood cancer survivors. Cancer Causes Control 2007 May;18(4):423-430. [CrossRef] [Medline]
- Nagler RH, Puleo E, Sprunck-Harrild K, Emmons KM. Internet use among childhood and young adult cancer survivors who smoke: implications for cessation interventions. Cancer Causes Control 2012 Apr;23(4):647-652 [FREE Full text] [CrossRef] [Medline]
- de Moor JS, Puleo E, Ford JS, Greenberg M, Hodgson DC, Tyc VL, et al. Disseminating a smoking cessation intervention to childhood and young adult cancer survivors: baseline characteristics and study design of the partnership for health-2 study. BMC Cancer 2011;11:165 [FREE Full text] [CrossRef] [Medline]
- Prochaska J, DiClemente C. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983 Jun;51(3):390-395. [Medline]
- Prokhorov AV, Yost T, Mullin-Jones M, de Moor C, Ford KH, Marani S, et al. "Look at your health": outcomes associated with a computer-assisted smoking cessation counseling intervention for community college students. Addict Behav 2008 Jun;33(6):757-771 [FREE Full text] [CrossRef] [Medline]
- Nelson DE, Kreps GL, Hesse BW, Croyle RT, Willis G, Arora NK, et al. The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun 2004;9(5):443-60; discussion 81. [CrossRef] [Medline]
- Murray DM, Perry CL. The measurement of substance use among adolescents: when is the 'bogus pipeline' method needed? Addict Behav 1987;12(3):225-233. [Medline]
- Murray DM, O'Connell CM, Schmid LA, Perry CL. The validity of smoking self-reports by adolescents: a reexamination of the bogus pipeline procedure. Addict Behav 1987;12(1):7-15. [Medline]
- Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991 Sep;86(9):1119-1127. [Medline]
- Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979 May;41(3):209-218 [FREE Full text] [Medline]
- Vigilante KC, Flynn MM, Affleck PC, Stunkle JC, Merriman NA, Flanigan TP, et al. Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning. J Womens Health 1999 Apr;8(3):409-415. [Medline]
- Tyc VL, Hadley W, Crockett G. Predictors of intentions to use tobacco among adolescent survivors of cancer. J Pediatr Psychol 2001 Mar;26(2):117-121 [FREE Full text] [Medline]
- Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997 Jul;12(7):439-445 [FREE Full text] [Medline]
- Yuan Y. Multiple imputation using SAS software. Journal of Statistical Software 2011 Dec;45(6):1-25.
- Graham AL, Cobb NK, Papandonatos GD, Moreno JL, Kang H, Tinkelman DG, et al. A randomized trial of Internet and telephone treatment for smoking cessation. Arch Intern Med 2011 Jan 10;171(1):46-53 [FREE Full text] [CrossRef] [Medline]
- Christensen H, Griffiths KM, Jorm AF. Delivering interventions for depression by using the internet: randomised controlled trial. BMJ 2004 Jan 31;328(7434):265 [FREE Full text] [CrossRef] [Medline]
- Christensen H, Griffiths KM, Korten AE, Brittliffe K, Groves C. A comparison of changes in anxiety and depression symptoms of spontaneous users and trial participants of a cognitive behavior therapy website. J Med Internet Res 2004 Dec 22;6(4):e46 [FREE Full text] [CrossRef] [Medline]
- Eysenbach G. The law of attrition. J Med Internet Res 2005;7(1):e11 [FREE Full text] [CrossRef] [Medline]
- Farvolden P, Denisoff E, Selby P, Bagby RM, Rudy L. Usage and longitudinal effectiveness of a Web-based self-help cognitive behavioral therapy program for panic disorder. J Med Internet Res 2005;7(1):e7 [FREE Full text] [CrossRef] [Medline]
- Samoocha D, Bruinvels DJ, Elbers NA, Anema JR, van der Beek AJ. Effectiveness of web-based interventions on patient empowerment: a systematic review and meta-analysis. J Med Internet Res 2010;12(2):e23 [FREE Full text] [CrossRef] [Medline]
- Anhøj J, Jensen AH. Using the internet for life style changes in diet and physical activity: a feasibility study. J Med Internet Res 2004 Sep 8;6(3):e28 [FREE Full text] [CrossRef] [Medline]
- Wu RC, Delgado D, Costigan J, Maciver J, Ross H. Pilot study of an Internet patient-physician communication tool for heart failure disease management. J Med Internet Res 2005;7(1):e8 [FREE Full text] [CrossRef] [Medline]
- Cobb NK, Graham AL, Bock BC, Papandonatos G, Abrams DB. Initial evaluation of a real-world Internet smoking cessation system. Nicotine Tob Res 2005 Apr;7(2):207-216 [FREE Full text] [CrossRef] [Medline]
- Muñoz RF, Barrera AZ, Delucchi K, Penilla C, Torres LD, Pérez-Stable EJ. International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year. Nicotine Tob Res 2009 Sep;11(9):1025-1034 [FREE Full text] [CrossRef] [Medline]
- Pike KJ, Rabius V, McAlister A, Geiger A. American Cancer Society's QuitLink: randomized trial of Internet assistance. Nicotine Tob Res 2007 Mar;9(3):415-420. [CrossRef] [Medline]
- Chiu TM, Eysenbach G. Stages of use: consideration, initiation, utilization, and outcomes of an internet-mediated intervention. BMC Med Inform Decis Mak 2010;10:73 [FREE Full text] [CrossRef] [Medline]
- Graham AL, Cha S, Papandonatos GD, Cobb NK, Mushro A, Fang Y, et al. Improving adherence to web-based cessation programs: a randomized controlled trial study protocol. Trials 2013;14:48 [FREE Full text] [CrossRef] [Medline]
- Richardson A, Graham AL, Cobb N, Xiao H, Mushro A, Abrams D, et al. Engagement promotes abstinence in a web-based cessation intervention: cohort study. J Med Internet Res 2013;15(1):e14 [FREE Full text] [CrossRef] [Medline]
- U.S. Department of Health and Human Services. Washington, DC; 2012. URL: http://www.healthypeople.gov/2020/default.aspx [accessed 2013-08-21] [WebCite Cache]
- Centers for Disease ControlPrevention (CDC). State medicaid coverage for tobacco-dependence treatments --- United States, 2009. MMWR Morb Mortal Wkly Rep 2010 Oct 22;59(41):1340-1343 [FREE Full text] [Medline]
- Land T, Warner D, Paskowsky M, Cammaerts A, Wetherell L, Kaufmann R, et al. Medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in smoking prevalence. PLoS One 2010;5(3):e9770 [FREE Full text] [CrossRef] [Medline]
- Land T, Rigotti NA, Levy DE, Paskowsky M, Warner D, Kwass JA, et al. A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease. PLoS Med 2010;7(12):e1000375 [FREE Full text] [CrossRef] [Medline]
- Fiore MC, Jaén CR. A clinical blueprint to accelerate the elimination of tobacco use. JAMA 2008 May 7;299(17):2083-2085. [CrossRef] [Medline]
- U.S. Department of Health and Human Services PHS. Clinical Practice Guideline, Number 18: Smoking Cessation. In: Agency for Health Care Policy and Research. Washington, DC: US Government Printing Office; 1996.
- Estabrooks PA, Boyle M, Emmons KM, Glasgow RE, Hesse BW, Kaplan RM, et al. Harmonized patient-reported data elements in the electronic health record: supporting meaningful use by primary care action on health behaviors and key psychosocial factors. J Am Med Inform Assoc 2012;19(4):575-582 [FREE Full text] [CrossRef] [Medline]
- Campo RA, Rowland JH, Irwin ML, Nathan PC, Gritz ER, Kinney AY. Cancer prevention after cancer: changing the paradigm--a report from the American Society of Preventive Oncology. Cancer Epidemiol Biomarkers Prev 2011 Oct;20(10):2317-2324 [FREE Full text] [CrossRef] [Medline]
- Goldstein AO, Ripley-Moffitt CE, Pathman DE, Patsakham KM. Tobacco use treatment at the U.S. National Cancer Institute's designated Cancer Centers. Nicotine Tob Res 2013 Jan;15(1):52-58. [CrossRef] [Medline]
- Park EB, Emmons KM, Malloy NW, Seifer E. A qualitative exploration of health perceptions and behaviors among adult survivors of childhood cancers. J Cancer Educ 2002;17(4):211-215. [CrossRef] [Medline]
- Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yasui Y, Hayashi R, et al. Childhood cancer survivors' knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study. JAMA 2002 Apr 10;287(14):1832-1839. [Medline]
- Bashore L. Childhood and adolescent cancer survivors' knowledge of their disease and effects of treatment. J Pediatr Oncol Nurs 2004;21(2):98-102. [Medline]
- Zeltzer LK, Recklitis C, Buchbinder D, Zebrack B, Casillas J, Tsao JC, et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2009 May 10;27(14):2396-2404 [FREE Full text] [CrossRef] [Medline]
- Wenninger K, Helmes A, Bengel J, Lauten M, Völkel S, Niemeyer CM. Coping in long-term survivors of childhood cancer: relations to psychological distress. Psychooncology 2013 Apr;22(4):854-861. [CrossRef] [Medline]
- Kazak AE, Derosa BW, Schwartz LA, Hobbie W, Carlson C, Ittenbach RF, et al. Psychological outcomes and health beliefs in adolescent and young adult survivors of childhood cancer and controls. J Clin Oncol 2010 Apr 20;28(12):2002-2007 [FREE Full text] [CrossRef] [Medline]
- Kottke TE, Solberg LI, Nelson AF, Belcher DW, Caplan W, Green LW, et al. Optimizing practice through research: a new perspective to solve an old problem. Ann Fam Med 2008;6(5):459-462 [FREE Full text] [CrossRef] [Medline]
- Glasgow RE, Lichtenstein E, Marcus AC. Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health 2003 Aug;93(8):1261-1267. [Medline]
- Green LW, Glasgow RE, Atkins D, Stange K. Making evidence from research more relevant, useful, and actionable in policy, program planning, and practice slips "twixt cup and lip". Am J Prev Med 2009 Dec;37(6 Suppl 1):S187-S191. [CrossRef] [Medline]
- Glasgow RE, Green LW, Klesges LM, Abrams DB, Fisher EB, Goldstein MG, et al. External validity: we need to do more. Ann Behav Med 2006 Apr;31(2):105-108. [CrossRef] [Medline]
- Green LW, Glasgow RE. Evaluating the relevance, generalization, and applicability of research: issues in external validation and translation methodology. Eval Health Prof 2006 Mar;29(1):126-153. [CrossRef] [Medline]
- Velicer WF, Prochaska JO, Rossi JS, Snow MG. Assessing outcome in smoking cessation studies. Psychol Bull 1992 Jan;111(1):23-41. [Medline]
- Eysenbach G, CONSORT-EHEALTH Group. CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res 2011;13(4):e126 [FREE Full text] [CrossRef] [Medline]
|BFR: baseline feedback report|
|IES: Impact of Events Scale|
|IRB: Institutional Review Board|
|PFH: Partnership for Health|
|PFH-2: Partnership for Health-2|
|PHS: Public Health Service|
Edited by G Eysenbach; submitted 18.01.13; peer-reviewed by J Studts, D Abrams; comments to author 26.03.13; revised version received 21.05.13; accepted 04.07.13; published 05.11.13Copyright
©Karen M Emmons, Elaine Puleo, Kim Sprunck-Harrild, Jennifer Ford, Jamie S Ostroff, David Hodgson, Mark Greenberg, Lisa Diller, Janet de Moor, Vida Tyc. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 05.11.2013.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.